Long hold plans (months to years) for every stock of the list: an accumulation zone with a buy-by time, average-down levels, sell points with dates, a weekly-close stop and the sell warnings. Watch list crypto of openstock, 10 stocks.
Updated 2026-10-30 21:30:02 ET · times are US Eastern
| 1 | CRCL | 52 | WATCH | 72.54 | – | – | Still in a downtrend (under a falling 50 week average): wait for a weekly close over it | |||
| 2 | HUT | 46 | AVOID | 59.40 | – | – | Fundamentals score 29: poor fundamentals | |||
| 3 | COIN | 42 | AVOID | 143.54 | – | – | Score 42: weak fundamentals, value or health | |||
| 4 | RIOT | 40 | AVOID | 12.81 | – | – | Toxic asset: Cash runway under 12 months (11.5 months); Altman Z'' under 1.1 (-0.72); warning signs: Negative EBITDA and free cash flow | |||
| 5 | ABTC | 40 | AVOID | 6.64 | – | – | Toxic asset: Reverse split in the last 12 months (1-for-15 on 2026-07-06); 2+ reverse splits in 3 years (3: 1-for-20 on 2024-02-09, 1-for-5 on 2025-09-03, 1-for-15 on 2026-07-06); Cash runway under 12 months (2.4 months); Altman Z'' under 1.1 (-0.80); warning signs: Current ratio under 1, Negative EBITDA and free cash flow | |||
| 6 | BTCT | 36 | AVOID | 0.6700 | – | – | Toxic asset: Cash runway under 12 months (8.5 months); Altman Z'' under 1.1 (-0.76); Price under $1 (exchange minimum bid) (0.74); warning signs: Negative EBITDA and free cash flow, Market cap under $25M | |||
| 7 | KEEL | 30 | AVOID | 2.06 | – | – | Fundamentals score 29: poor fundamentals | |||
| 8 | MARA | 30 | AVOID | 6.77 | – | – | Toxic asset: Cash runway under 12 months (5.6 months); Altman Z'' under 1.1 (-3.87); warning signs: Current ratio under 1, Negative EBITDA and free cash flow | |||
| 9 | BTBT | 30 | AVOID | 0.8000 | – | – | Toxic asset: Cash runway under 12 months (3.6 months); Altman Z'' under 1.1 (-0.57); Price under $1 (exchange minimum bid) (0.92); warning signs: Negative EBITDA and free cash flow, Debt above the market cap | |||
| 10 | WULF | 26 | AVOID | 11.73 | – | – | Fundamentals score 19: poor fundamentals |
Price 72.54 · fundamentals 69/100 · cap 20.81B · 76% under its 5y high · 0.84x the 200 day · 1y vs SPY -50%
No entry plan: Still in a downtrend (under a falling 50 week average): wait for a weekly close over it
fundamentals 69/100 (fair); 76% under its 5 year high; 0.84x the 200 day average; 1y -50% vs SPY; trend -42% a year
Price 59.40 · fundamentals 29/100 · cap 8.30B · 58% under its 5y high · 0.72x the 200 day · 1y vs SPY +3%
No entry plan: Fundamentals score 29: poor fundamentals
fundamentals 29/100 (poor); 58% under its 5 year high; 0.72x the 200 day average; 1y +3% vs SPY; trend +148% a year
Price 143.54 · fundamentals 47/100 · cap 42.50B · 68% under its 5y high · 0.81x the 200 day · 1y vs SPY -63%
No entry plan: Score 42: weak fundamentals, value or health
fundamentals 47/100 (weak); 68% under its 5 year high; 0.81x the 200 day average; 1y -63% vs SPY; trend +5% a year
Price 12.81 · fundamentals 43/100 · cap 5.09B · 72% under its 5y high · 0.66x the 200 day · 1y vs SPY -48%
No entry plan: Toxic asset: Cash runway under 12 months (11.5 months); Altman Z'' under 1.1 (-0.72); warning signs: Negative EBITDA and free cash flow
fundamentals 43/100 (toxic); 72% under its 5 year high; 0.66x the 200 day average; 1y -48% vs SPY; trend +28% a year
Price 6.64 · fundamentals 55/100 · cap 564.35M · 100% under its 5y high · 0.53x the 200 day · 1y vs SPY -93%
No entry plan: Toxic asset: Reverse split in the last 12 months (1-for-15 on 2026-07-06); 2+ reverse splits in 3 years (3: 1-for-20 on 2024-02-09, 1-for-5 on 2025-09-03, 1-for-15 on 2026-07-06); Cash runway under 12 months (2.4 months); Altman Z'' under 1.1 (-0.80); warning signs: Current ratio under 1, Negative EBITDA and free cash flow
fundamentals 55/100 (toxic); 100% under its 5 year high; 0.53x the 200 day average; 1y -93% vs SPY; trend -67% a year
Price 0.6700 · fundamentals 37/100 · cap 8.75M · 100% under its 5y high · 0.59x the 200 day · 1y vs SPY -75%
No entry plan: Toxic asset: Cash runway under 12 months (8.5 months); Altman Z'' under 1.1 (-0.76); Price under $1 (exchange minimum bid) (0.74); warning signs: Negative EBITDA and free cash flow, Market cap under $25M
fundamentals 37/100 (toxic); 100% under its 5 year high; 0.59x the 200 day average; 1y -75% vs SPY; trend -36% a year
Price 2.06 · fundamentals 29/100 · cap 1.39B · 78% under its 5y high · 0.60x the 200 day · 1y vs SPY -56%
No entry plan: Fundamentals score 29: poor fundamentals
fundamentals 29/100 (poor); 78% under its 5 year high; 0.60x the 200 day average; 1y -56% vs SPY; trend +22% a year
Price 6.77 · fundamentals 31/100 · cap 2.74B · 92% under its 5y high · 0.63x the 200 day · 1y vs SPY -68%
No entry plan: Toxic asset: Cash runway under 12 months (5.6 months); Altman Z'' under 1.1 (-3.87); warning signs: Current ratio under 1, Negative EBITDA and free cash flow
fundamentals 31/100 (toxic); 92% under its 5 year high; 0.63x the 200 day average; 1y -68% vs SPY; trend -20% a year
Price 0.8000 · fundamentals 36/100 · cap 330.02M · 94% under its 5y high · 0.49x the 200 day · 1y vs SPY -81%
No entry plan: Toxic asset: Cash runway under 12 months (3.6 months); Altman Z'' under 1.1 (-0.57); Price under $1 (exchange minimum bid) (0.92); warning signs: Negative EBITDA and free cash flow, Debt above the market cap
fundamentals 36/100 (toxic); 94% under its 5 year high; 0.49x the 200 day average; 1y -81% vs SPY; trend -21% a year
Price 11.73 · fundamentals 19/100 · cap 6.32B · 69% under its 5y high · 0.65x the 200 day · 1y vs SPY -27%
No entry plan: Fundamentals score 19: poor fundamentals
fundamentals 19/100 (poor); 69% under its 5 year high; 0.65x the 200 day average; 1y -27% vs SPY; trend +149% a year; At risk: Altman Z'' under 1.1 (-2.20); warning signs: Current ratio under 1, Negative EBITDA and free cash flow
| No closed plans yet. | |||||
FAM long hold score 0-100: company fundamentals 50 (profitability, valuation, financial health, growth, analyst view), value 20 (under the 5 year high, price against the 200 day average), health 30 (200 day and 50 week averages, weekly RSI, a year vs SPY, trend line). Rating: BUY (accumulate now), ACCUMULATE (a good company, but stretched: the zone waits near the 200 day average), WATCH (limited data, overheated, a downtrend or a low score), AVOID (weak fundamentals or a toxic asset). Open the fundamentals report of a stock for every check. Warnings: SELL sells what is left now, TRIM takes some profit, WATCH is a heads up. After a stop or a sell signal a stock sits out for 14 days. Not financial advice.
